ƒz[ƒ€ > ­ô‚ɂ‚¢‚Ä > •ª–ì•Ê‚̐­ôˆê—— > ‘¼•ª–ì‚ÌŽæ‚è‘g‚Ý > Œ¤‹†Ž–‹Æ > •½¬28”N“x@Œú¶˜J“­‰ÈŠwŒ¤‹†‚ÌŠT—v > Ž–‘O•]‰¿ˆÏˆõ‰ï–¼•ë > ƒGƒCƒY‘΍ô­ôŒ¤‹†Ž–‹Æ

•½¬28”N“xƒGƒCƒY‘΍ô­ôŒ¤‹†Ž–‹Æ Ž–‘O•]‰¿ˆÏˆõ–¼•ë

i›FˆÏˆõ’·j

 
’rã@çŽõŽq “Á’è”ñ‰c—˜Šˆ“®–@l‚Õ‚ê‚¢‚·“Œ‹ž—Ž–
ƒZƒNƒ\ƒƒW[
u«‚ɂ‚¢‚ÄŒê‚낤@Žq‚Ç‚à‚ƈꏏ‚ɍl‚¦‚év’rãçŽõŽq’˜AŠâ”gƒuƒbƒNƒŒƒbƒgA2013
uŽv‚¢‚±‚݂̐«AƒŠƒXƒL[‚ȃZƒbƒNƒXv’rãçŽõŽq’˜AŠâ”g‘“XA2011
u21¢‹I‚̉ۑ聁¡‚±‚»AƒGƒCƒY‚ðl‚¦‚év’rãçŽõŽq’˜@à’c–@l“ú–{«‹³ˆç‹¦‰ï@«‹³ˆçƒnƒ“ƒhƒuƒbƒNvol.5 2011
 
¡‘º@’m–¾ “Þ—ÇŒ§—§ˆã‰È‘åŠw‹³Žö
ŒöO‰q¶ŠwAŒ’N­ôˆãŠwAˆã—Эô
‚`‚h‚c‚r^Š´õŽÒV‹K•ñ”ä—¦|‚¢‚í‚ä‚éu‚¢‚«‚È‚è‚`‚h‚c‚r—¦v|‚ÌŒŸ“¢. ¬ìr•vA”’â‘ô–A¡‘º’m–¾. “ú–{ƒGƒCƒYŠw‰ïŽ. 2012 Feb;14(1):46-54.
‚g‚h‚uf—ÂɊւí‚錴‰¿‚ÌŽÀ‘Ô’²¸. ˆäo”Ž¶AÔ‰HŠwA”’ã‘ô–A¡‘º’m–¾. “ú–{ƒGƒCƒYŠw‰ïŽ. 2010 Feb;12(1):49-55.
History of public health crises in Japan. Imamura T, Ide H, Yasunaga H. J Public Health Policy. 2007 Nov;28(2):221-237
 
Šâ–{@ˆ¤‹g ‘—§Œ¤‹†ŠJ”­–@l “ú–{ˆã—ÃŒ¤‹†ŠJ”­‹@\ ‰ÈŠw‹ZpŒÚ–â
HIVŠ´õÇAŠ´õÇ“à‰ÈAƒEƒCƒ‹ƒXŠw
Rapid HIV-1 disease progression in individuals infected with a viru adapted to its host population. Katoh, J., Kawana-Tachikawa, A., Shimizu, A., Zhu, D., Han, C., Nakamura, H., Koga, M., Kikuchi, T., Adachi, E., Koibuchi, T., Gao, G.F., Brumme, Z.L., and Iwamoto, A. PLoS ONE 11 (3): e0150397. Doi:10.1371/journal.pone.0150397. (Published on March 8, 2016)
Switching and emergence of CTL epitopes in HIV-1 infection. Han, C., Kawana-Tachikawa, A., Shimizu, A., Zhu, D., Nakamura, H., Adachi, E., Kikuchi, T., Koga, M., Koibuchi, T., Gao, GF., Sato, Y., Yamagata, A., Martin, E., Fukai, S., Brumme, ZL., and Iwamoto, A. Retrovirology 11:38, 2014.  doi:10.1186/1742-4690-11-38, 2014. (Published May 21, 2014)
uStructure of TCR and antigen complexes at an immunodominant CTL epitope in HIV-1 infection. Shimizu, A., Kawana-Tachikawa, A., Yamagata, A., Han, C., Zhu, D., Sato, Y., Nakamura, H., Koibuchi, T., Carlson, J., Martin, E., Brumme, C.J., Shi, Y., Gao, G.F., Brumme, Z.L., Fukai, S., and Iwamoto, A. Sci. Rep. 3: 3097, 2013; doi: 10.1038/srep03097(2013).
 
¬–쎛@ºˆê •xŽmŽs—§’†‰›•a‰@E‰@’·A“Œ‹žŽœŒb‰ïˆã‰È‘åŠw‹qˆõ‹³Žö
”å”AŠí‰ÈA”A˜HE«ŠíŠ´õÇAŠ´õ§Œä
Comparison of free and anonymous testing for HIV and sexually@transmitted infections between the University Hospital and Health@Center. Yoshida M, Chiba A, Kawano S, Kato T, Sato F, Horino T, Nakazawa Y, Yoshikawa K, Onodera S, Hori S. J Infect Chemother. 2012 Mar 23.[Epub ahead of print]
HIVŠ´õŽÒ‚Ì”~“Å‚ÉŠÖ‚·‚錟“¢.²“¡•¶Æ,‰Í–ì^“ñ,‰Á“¡“N˜N,–x–ì“N–ç,’†àV –õ,‹gìWŽi,‹g“c³Ž÷,¬–쎛ºˆê.“ú«Š´õÇ‰ïŽ20i1jF2009F192-197.
¬–쎛ºˆêFŒú¶˜J“­‰ÈŠwŒ¤‹†•â•‹à VŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒU“™V‹»EÄ‹»Š´õÇŒ¤‹†Ž–‹Æu«Š´õÇ‚ÉŠÖ‚·‚é—\–hAŽ¡—Â̑̌n‰»‚ÉŠÖ‚·‚錤‹†viŒ¤‹†‘ã•\ŽÒF¬–쎛ºˆêj•½¬21”N“x`•½¬23”N“x‘‡Œ¤‹†•ñ‘
›
‘q“c@‹B ‘Ûˆã—ÕŸŽƒ‘åŠw‰–’J•a‰@@’†‰›ŒŸ¸•”’·
ƒEƒCƒ‹ƒXŠ´õÇ‚Ì”­Ç•a—Šw
–UŒŸ—á‚©‚ç‚Ý‚½“ú–{‚̃GƒCƒY
‘q“c‹BA¬’r·—YAX–ΗY•Ò’˜
Œú¶˜J“­È‰ÈŠwŒ¤‹†”ï‚É‚æ‚錤‹†•ñ‘A•½¬5”N8ŒŽ
Topoisomerase 1 and ATP activate DNA synthesis of human immune-Deficiency virus type 1(HIV-1). BBRC294:509-517, 2002.
Takahashi H., Sawa H., Hasegawa H., Shoya Y., Sata T.,@Hall WW., Nagashima K., and Kurata T.i˜A‘±3•Òj
•aŒ´×‹Û|ƒEƒCƒ‹ƒX}ŠÓ
•Ò’˜@V‹Žu˜YA‘q“c‹BA—щp¶A–{“c•ŽiA¬“chA¼–{–¾@
–k‘åo”ʼnï@2017
 
‘ŠŠy@—TŽq Š‘®‚È‚µ
—Տ°Š´õÇŠw
“ˆ‹MŽqC{“¡O“ñC‹ß“¡^‹KŽqC‘qˆä‰ØŽqC‘ŠŠy—TŽqC¡ˆäŒõMFŒuŒõy‘f–Ɖu‘ª’è–@‚É‚æ‚éV‚µ‚¢HIVRŒ´R‘Ì“¯ŽžŒŸoŽŽ–òi‘æ4¢‘ãj‚ÌŒŸ“¢DŠ´õÇŠw‰ïŽ81F562-572C2007
’ËŒ´—DŒÈC‘ŠŠy—TŽqCŠì‘½P˜aC“ˆ‹MŽqC–î‰i—R—ŽqCŠOì³¶C‘å‹à”ü˜aCˆî—tŒ›”VF‘æ20‰ñ“ú–{ƒGƒCƒYŠw‰ïƒVƒ“ƒ|ƒWƒEƒ€ Š´õ—«‚Ì”DPEoŽYEˆçŽ™Žx‰‡D“ú–{ƒGƒCƒYŠw‰ïŽ9F116-119C2007D
Mohri S, Yoshikawa K, Sagara H, Nakajima, HFA case of Penicillium marneffei infection in an AIDS patient -the first case in Japan-. Jpn J
Med Mycol 41: 23-26, 2000.
 
‹{“c@ˆê—Y ƒGƒCƒY—\–hà’c—Ž–
î•ñAŒ[”­
wNO TIME TO LOSE iƒm[Eƒ^ƒCƒ€EƒgƒDEƒ‹[ƒYj\ ƒGƒ{ƒ‰‚ƃGƒCƒY‚ƍ‘Û­Ž¡xƒs[ƒ^[EƒsƒIƒbƒgi‹{“cˆê—YE’Mˆä³‹`E‘呺•üŽq–ójŒcœä‹`m‘åŠwo”ʼnï 2015”N
wVƒGƒCƒY—\–hŽwj‚ÆŽ„‚½‚¿xi•Ò’˜j ƒGƒCƒY—\–hà’c•Òi‹{“cˆê—YE‰iˆÕŽŠ•¶j ˜A‡o”Å 2012”N
w¢ŠE‚̓GƒCƒY‚Æ‚Ç‚¤“¬‚Á‚Ä‚«‚½‚Ì‚©x ‹{“cˆê—Y ƒ|ƒbƒgo”Å 2002”N

ƒz[ƒ€ > ­ô‚ɂ‚¢‚Ä > •ª–ì•Ê‚̐­ôˆê—— > ‘¼•ª–ì‚ÌŽæ‚è‘g‚Ý > Œ¤‹†Ž–‹Æ > •½¬28”N“x@Œú¶˜J“­‰ÈŠwŒ¤‹†‚ÌŠT—v > Ž–‘O•]‰¿ˆÏˆõ‰ï–¼•ë > ƒGƒCƒY‘΍ô­ôŒ¤‹†Ž–‹Æ

ƒy[ƒW‚̐擪‚Ö–ß‚é